Search Results - "Spinaci, Andrea"

Refine Results
  1. 1

    Combined Therapy of A1AR Agonists and A2AAR Antagonists in Neuroinflammation by Marucci, Gabriella, Ben, Diego Dal, Lambertucci, Catia, Navia, Aleix Martí, Spinaci, Andrea, Volpini, Rosaria, Buccioni, Michela

    Published in Molecules (Basel, Switzerland) (23-02-2021)
    “…Alzheimer’s, Parkinson’s, and multiple sclerosis are neurodegenerative diseases related by neuronal degeneration and death in specific areas of the central…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A2A Adenosine Receptor Useful in Neurodegenerative Disorders by Francucci, Beatrice, Angeloni, Simone, Dal Ben, Diego, Lambertucci, Catia, Ricciutelli, Massimo, Spinaci, Andrea, Smirnov, Aleksei, Volpini, Rosaria, Buccioni, Michela, Marucci, Gabriella

    Published in Molecules (Basel, Switzerland) (14-06-2023)
    “…Currently, the number of patients with neurodegenerative pathologies is estimated at over one million, with consequences also on the economic level. Several…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The G Protein-Coupled Receptor GPR17: Overview and Update by Marucci, Gabriella, Dal Ben, Diego, Lambertucci, Catia, Santinelli, Claudia, Spinaci, Andrea, Thomas, Ajiroghene, Volpini, Rosaria, Buccioni, Michela

    Published in ChemMedChem (06-12-2016)
    “…The GPR17 receptor is a G protein‐coupled receptor (GPCR) that seems to respond to two unrelated families of endogenous ligands: nucleotide sugars (UDP,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity by Spinaci, Andrea, Buccioni, Michela, Dal Ben, Diego, Maggi, Federica, Marucci, Gabriella, Francucci, Beatrice, Santoni, Giorgio, Lambertucci, Catia, Volpini, Rosaria

    Published in Pharmaceuticals (Basel, Switzerland) (28-01-2022)
    “…The overexpression of the A3 adenosine receptor (AR) in a number of cancer cell types makes it an attractive target for tumor diagnosis and therapy. Hence, in…”
    Get full text
    Journal Article
  8. 8

    Adenosine receptors as neuroinflammation modulators: role of A1 agonists and A2A antagonists by Martí Navia, Aleix, Dal Ben, Diego, Lambertucci, Catia, Spinaci, Andrea, Volpini, Rosaria, Marques-Morgado, Inês, Coelho, Joana, Lopes, Luisa, Marucci, Gabriella, Buccioni, Michela

    Published in Cells (Basel, Switzerland) (21-07-2020)
    “…© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Non-Nucleoside Agonists of the Adenosine Receptors: An Overview by Dal Ben, Diego, Lambertucci, Catia, Buccioni, Michela, Martí Navia, Aleix, Marucci, Gabriella, Spinaci, Andrea, Volpini, Rosaria

    Published in Pharmaceuticals (Basel, Switzerland) (08-10-2019)
    “…Potent and selective adenosine receptor (AR) agonists are of pharmacological interest for the treatment of a wide range of diseases and conditions. Among these…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications by Marucci, Gabriella, Dal Ben, Diego, Buccioni, Michela, Martí Navia, Aleix, Spinaci, Andrea, Volpini, Rosaria, Lambertucci, Catia

    Published in Expert opinion on therapeutic patents (02-12-2019)
    “…: Purinergic P2X3-P2X2/3 receptors are placed in nociceptive neurons' strategic location and show unique desensitization properties; hence, they represent an…”
    Get more information
    Journal Article
  14. 14

    A patent review of adenosine A 2B receptor antagonists (2016-present) by Francucci, Beatrice, Dal Ben, Diego, Lambertucci, Catia, Spinaci, Andrea, Volpini, Rosaria, Marucci, Gabriella, Buccioni, Michela

    Published in Expert opinion on therapeutic patents (03-06-2022)
    “…A adenosine receptor (A AR) plays a crucial role in pathophysiologic conditions associated with high adenosine release, typical of airway inflammatory…”
    Get more information
    Journal Article
  15. 15

    Dual Anta-Inhibitors Targeting Protein Kinase CK1δ and A[sub.2A] Adenosine Receptor Useful in Neurodegenerative Disorders by Francucci, Beatrice, Angeloni, Simone, Dal Ben, Diego, Lambertucci, Catia, Ricciutelli, Massimo, Spinaci, Andrea, Smirnov, Aleksei, Volpini, Rosaria, Buccioni, Michela, Marucci, Gabriella

    Published in Molecules (Basel, Switzerland) (01-06-2023)
    “…Currently, the number of patients with neurodegenerative pathologies is estimated at over one million, with consequences also on the economic level. Several…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A 3 Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity by Spinaci, Andrea, Buccioni, Michela, Dal Ben, Diego, Maggi, Federica, Marucci, Gabriella, Francucci, Beatrice, Santoni, Giorgio, Lambertucci, Catia, Volpini, Rosaria

    Published in Pharmaceuticals (Basel, Switzerland) (28-01-2022)
    “…The overexpression of the A adenosine receptor (AR) in a number of cancer cell types makes it an attractive target for tumor diagnosis and therapy. Hence, in…”
    Get full text
    Journal Article
  18. 18

    New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases by Lambertucci, Catia, Marucci, Gabriella, Dal Ben, Diego, Buccioni, Michela, Spinaci, Andrea, Kachler, Sonja, Klotz, Karl-Norbert, Volpini, Rosaria

    Published in European journal of medicinal chemistry (10-05-2018)
    “…The synthesis of 9-alkyl substituted adenine derivatives presenting aromatic groups and cycloalkyl rings in 8- and N6-position, respectively, is reported. The…”
    Get full text
    Journal Article
  19. 19

    Adenine derivatives as inhibitors of the casein kinase CK1delta enzyme by Spinaci, Andrea, Lambertucci, Catia, Chang, Cui, Buccioni, Michela, Marucci, Gabriella, Cescon, Eleonora, Federico, Stephanie, Spalluto, Giampiero, Dal Ben, Diego, Volpini, Rosaria

    Published in Medicinal chemistry research (01-04-2024)
    “…Overexpression of CK1δ has been associated to the development of cancer and neurodegenerative disorders, making ligands of this protein very promising drug…”
    Get full text
    Journal Article
  20. 20